Q4 2023 Holdings
Filed 2024-02-14 | 74 holdings | $2.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Avantor Inc(AVTR) | COM | 05352A100 | $48.4M | 2,121,844 | 1.8% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $49.1M | 1,148,308 | 1.8% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $49.5M | 85,000 | 1.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $50.9M | 710,000 | 1.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $51.5M | 1,719,103 | 1.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $52.2M | 237,202 | 1.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $54.1M | 1,520,000 | 2.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $54.2M | 1,829,215 | 2.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $56.7M | 615,000 | 2.1% |
| CVS Health Corp(CVS) | COM | 126650100 | $58.4M | 740,000 | 2.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $59.7M | 68,000 | 2.2% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $60.2M | 489,119 | 2.2% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $62.5M | 6,500,328 | 2.3% |
| Karuna Therapeutics Inc | COM | 48576A100 | $65.2M | 206,000 | 2.4% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $65.8M | 871,000 | 2.4% |
| Danaher Corporation(DHR) | COM | 235851102 | $67.1M | 290,000 | 2.4% |
| Natera Inc(NTRA) | COM | 632307104 | $69.5M | 1,110,000 | 2.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $85.4M | 3,950,000 | 3.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $86.7M | 658,000 | 3.2% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $89.9M | 1,156,692 | 3.3% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $96.9M | 182,600 | 3.5% |
| The Cigna Group(CI)Call | COM | 125523100 | $104.8M | 350,000 | 3.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $109.3M | 1,890,000 | 4.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $122.9M | 2,985,117 | 4.5% |